Moderna surged as investors turned eyed potential demand for a vaccine to protect against bird flu after the US reported its ...

The S&P 500 fell 1.1% on Tuesday, Jan. 7, as U.S. manufacturing data reinvigorated concerns about inflation and the interest ...

Shares of vaccine makers including Moderna, Novavax and CureVac rose Tuesday after U.S. health officials confirmed the first ...

The company is one of a few drugmakers currently developing a vaccine for the illness, which is spreading rapidly through ...

Key Takeaways Moderna shares jumped more than 10% to lead S&P 500 gainers Tuesday, a day after the first bird-flu death was ...

Moderna stock was on track to see a weekly gain of 10% as of Wednesday following the first reported bird flu death in the US.

Moderna stock has been volatile this week as the first death in the U.S. connected to bird flu was reported. Here's what you ...

Moderna stock was on track to see a weekly gain of 10% as of Wednesday following the first reported bird flu death in the US.

A 13-year-old girl in Canada became so sick with H5N1, or bird flu, in late 2024 that she had to be put on a ventilator.

Shares of Moderna (MRNA), one of a few drugmakers currently developing a vaccine for the H5N1 bird flu, were up nearly 10% in early trading ...

Moderna stock was on track to see a weekly gain of over 20% as of Wednesday following the first reported bird flu death in the US.

Bird flu has severely impacted poultry farms and cattle herds across 16 states, marking the worst outbreak of its kind.